EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitochondrial Antiviral Signaling Protein Activation by Retinoic Acid-Inducible Gene I Agonist Triggers Potent Antiviral Defense in Umbilical Cord Mesenchymal Stromal Cells Without Compromising Mitochondrial Function

Sebastián Castillo-Galán iD, Felipe Grünenwald, Yessia Hidalgo, J César Cárdenas iD, Maria Ignacia Cadiz, Francisca Alcayaga-Miranda iD, Maroun Khoury, Jimena Cuenca iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26104686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sebastián Castillo-Galán und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación e Innovación Biomédica (CIIB), Universidad de los Andes, Santiago 7550000, Chile. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Mitochondria, Umbilical Cord, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo Nacional de Desarrollo Científico y Tecnológico, ANID-Basal funding for Scientific and Technological Center of Excellence (IMPACT), ANID-FONDECYT Postdoctorado.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenchymal stromal cells (MSCs) represent a promising therapeutic approach in viral infection management. However, their interaction with viruses remains poorly understood. MSCs can support antiviral immune responses and act as viral reservoirs, potentially compromising their therapeutic potential. Innate immune system recognition of viral pathogens involves pattern recognition receptors (PRRs), including RIG-I-like receptors (RLRs), which activate mitochondrial antiviral signaling protein (MAVS). MAVS triggers antiviral pathways like IRF3 and NF-κB, leading to interferon (IFN) production and pro-inflammatory responses. This study explores the antiviral response in umbilical cord-derived MSCs (UC-MSCs) through targeted stimulation with influenza A virus-derived 5′triphosphate-RNA (3p-hpRNA), a RIG-I agonist. By investigating MAVS activation, we provide mechanistic insights into the immune response at the molecular level. Our findings reveal that 3p-hpRNA stimulation triggers immune activation of the IRF3 and NF-κB pathways through MAVS. Subsequently, this leads to the induction of type I and III IFNs, IFN-stimulated genes (ISGs), and pro-inflammatory cytokines. Critically, this immune activation occurs without compromising mitochondrial integrity. UC-MSCs retain their capacity for mitochondrial transfer to recipient cells. These results highlight the adaptability of UC-MSCs, offering a nuanced understanding of immune responses balancing activation with metabolic integrity. Finally, our research provides mechanistic evidence for MSC-based interventions against viral infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsMitochondriaUmbilical CordAdaptor Proteins, Signal TransducingDEAD Box Protein 58HumansSignal TransductionInterferon Regulatory Factor-3NF-kappa BImmunity, InnateInfluenza A virusCells, CulturedAntiviral AgentsReceptors, Immunologic

Stichwörter der Autor:innen

MAVSRIG-I agonistcellular and mitochondrial functionmesenchymal stromal cellsviral RNA

Substanzen

MAVS protein, humanAdaptor Proteins, Signal TransducingInterferon Regulatory Factor-3DEAD Box Protein 58NF-kappa BRIGI protein, humanIRF3 protein, humanAntiviral AgentsReceptors, Immunologic

Autor:innen und Institutionen

  • Centro de Investigación e Innovación Biomédica (CIIB), Universidad de los Andes, Santiago 7550000, Chile.
  • IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Santiago 7550000, Chile.
  • Center for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago 750000, Chile.
  • Geroscience Center for Brain Health and Metabolism, Santiago 7750000, Chile.
  • Department of Chemistry and Biochemistry, University of California, Santa Barbara, CA 93101, USA.
  • Cells for Cells, Santiago 7550000, Chile.

ORCID-Profile: Sebastián Castillo-Galán, J César Cárdenas, Francisca Alcayaga-Miranda, Jimena Cuenca

Förderung

  • Fondo Nacional de Desarrollo Científico y Tecnológico
  • ANID-Basal funding for Scientific and Technological Center of Excellence (IMPACT)
  • ANID-FONDECYT Postdoctorado
  • ANID-FONDECYT Initiation Grant
  • FONDECYT ANID/FONDAP
  • ANID/FONDECYT
  • ANID-FONDECYT
  • ANID—Basal funding for Scientific and Technological Center of Excellence (IMPACT)

Zitieren

APA

Castillo-Galán, S., Grünenwald, F., Hidalgo, Y., Cárdenas, J. C., Cadiz, M. I., Alcayaga-Miranda, F., Khoury, M., & Cuenca, J. (2025). Mitochondrial Antiviral Signaling Protein Activation by Retinoic Acid-Inducible Gene I Agonist Triggers Potent Antiviral Defense in Umbilical Cord Mesenchymal Stromal Cells Without Compromising Mitochondrial Function. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104686

Vancouver

Castillo-Galán S, Grünenwald F, Hidalgo Y, Cárdenas JC, Cadiz MI, Alcayaga-Miranda F, et al. Mitochondrial Antiviral Signaling Protein Activation by Retinoic Acid-Inducible Gene I Agonist Triggers Potent Antiviral Defense in Umbilical Cord Mesenchymal Stromal Cells Without Compromising Mitochondrial Function. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104686

BibTeX
@article{CastilloGaln2025,
  author = {Castillo-Galán, Sebastián and Grünenwald, Felipe and Hidalgo, Yessia and Cárdenas, J César and Cadiz, Maria Ignacia and Alcayaga-Miranda, Francisca and Khoury, Maroun and Cuenca, Jimena},
  title = {Mitochondrial Antiviral Signaling Protein Activation by Retinoic Acid-Inducible Gene I Agonist Triggers Potent Antiviral Defense in Umbilical Cord Mesenchymal Stromal Cells Without Compromising Mitochondrial Function},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26104686}
}
Kostenlos starten →